An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase

Area of Science:

• Molecular Biology
• Virology
• Biochemistry

Background:

• Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) is a key target for antiviral therapies.
• Studying mutations in the HIV-1 RT gene is crucial for understanding drug resistance and viral evolution.
• Existing methods for generating mutated RTs can be inefficient and complex.

Purpose of the Study:

• To develop a facile gene system for producing multiply substituted HIV-1 RTs.
• To enzymatically characterize these mutated RTs.
• To study the impact of RT mutations in a relevant HIV-1 genetic background.

Main Methods:

• Introduction of thirteen unique silent restriction sites into the HIV-1 pol gene.
• Optimized expression of viral protease for p66/p51 heterodimer generation in E. coli.
• Reintroduction of modified RT gene into recombinant proviral AD8 HIV-1 DNA.
• Biochemical characterization using active-site titration and pre-steady-state kinetics.
• Virological assessment of infectious virus production and infectivity.

Main Results:

• The developed system efficiently produces active, multiply substituted HIV-1 RTs.
• The pol gene tolerates numerous silent mutations in the polymerase domain without compromising viral functionality.
• Infectious viruses produced using the modified system were indistinguishable from wild-type AD8 HIV-1.
• The system was validated using the V75T substitution linked to stavudine resistance.

Conclusions:

• A novel and efficient gene system for generating and studying mutated HIV-1 RTs has been established.
• The HIV-1 pol gene is highly tolerant to silent mutations, offering flexibility for genetic manipulation.
• This system facilitates genotype-phenotype correlations and the study of drug resistance mechanisms in HIV-1.